{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:46:04Z","timestamp":1793929564762,"version":"4.8.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The prevalence of adrenal incidentaloma (AI) in imaging studies, including those of the adrenal glands, is estimated to be 1\u20135%. Essential factors for the proper management of AI include a correct diagnosis, adequate surgical skills, appropriate perioperative management, and sound dialogue with the patient. Aside from the possibility of overdiagnosis, patients with apparent signs or symptoms attributable to adrenal hormone excess have reasonable indications for surgery. At the same time, milder patients may be candidates for active surveillance without intervention. Even individuals with nonfunctioning AI may benefit from surgery if imaging studies depict the tumor as suggestive of malignancy. However, a differential diagnosis of AI may not be easy for surgeons with little experience in seeing such patients.<\/jats:p><jats:p>Furthermore, a patient without a correct diagnosis may miss the window of opportunity for a cure or incur a greater risk of developing complications, such as adrenal insufficiency or cardiovascular events during or after surgery, due to inadequate management. The clinical practice guidelines for AI from around the world may be helpful for shared decision-making; however, Japan lacks established guidelines. In this review article, we propose practical guidelines relevant to management by summarizing the evidence for five key questions that are often asked in dialog with patients with AI.<\/jats:p>","DOI":"10.1007\/s00595-023-02781-y","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T12:02:14Z","timestamp":1702468934000},"page":"1417-1427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Diagnosis and management of adrenal incidentaloma: use of clinical judgment and evidence in dialog with the patient"],"prefix":"10.1007","volume":"54","author":[{"given":"Yusaku","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyomi","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"issue":"2","key":"2781_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1507\/endocrj.EJ18-0486","volume":"67","author":"T Ichijo","year":"2020","unstructured":"Ichijo T, Ueshiba H, Nawata H, Yanase T. A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features. Endocr J. 2020;67(2):141\u201352.","journal-title":"Endocr J"},{"issue":"107\u2013125","key":"2781_CR2","first-page":"ix","volume":"29","author":"F Mantero","year":"2000","unstructured":"Mantero F, Amandi G. Management approaches to adrenal incidentalomas. A view from Ancona, Italy. Endocrinol Metab Clin North Am. 2000;29(107\u2013125):ix.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2781_CR3","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, et al. Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol. 2016;175:G1\u201334.","journal-title":"Eur J Endocrinol"},{"key":"2781_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMcp065470","volume":"356","author":"WF Young Jr","year":"2007","unstructured":"Young WF Jr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med. 2007;356:601\u201310.","journal-title":"N Engl J Med"},{"key":"2781_CR5","first-page":"228","volume-title":"Overdiagnosed: Making people sick in the pursuit of health","author":"HG Welch","year":"2011","unstructured":"Welch HG. Overdiagnosed: Making people sick in the pursuit of health. Boston: Beacon Press; 2011. p. 228."},{"key":"2781_CR6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/00000658-199906000-00001","volume":"229","author":"RE Goldstein","year":"1999","unstructured":"Goldstein RE, O\u2019Neill JA, Holcomb GW III, Morgan WM III, Neblett WW III, Oates JA, et al. Clinical experience over 48 years with pheochromocytoma. Ann Surg. 1999;229:755\u201364.","journal-title":"Ann Surg"},{"key":"2781_CR7","first-page":"1480","volume":"86","author":"PF Plouin","year":"2001","unstructured":"Plouin PF, Duclos JM, Soppelsa F, Boublil G, Chatellier G. Factors associated with perioperative morbidity in patients with pheochromocytoma\u202f: analysis of 165 operations at a single center. J Clin Endocrinol Metab. 2001;86:1480\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"2781_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.7326\/0003-4819-138-5-200303040-00013","volume":"138","author":"MM Grumbach","year":"2003","unstructured":"Grumbach MM, Biller BM, Braunstein GD, Cambell KK, Carney JA, Godley PA, et al. Management of the clinically inapparent adrenal mass (\u201cincidentaloma). Ann Intern Med. 2003;138:424\u20139.","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"2781_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP.15.S1.1","volume":"15","author":"MA Zeiger","year":"2009","unstructured":"Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, et al. American association of clinical endocrinologists and American association of endocrine surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract. 2009;15(Suppl 1):1\u201320.","journal-title":"Endocr Pract"},{"key":"2781_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3803\/EnM.2017.32.2.200","volume":"32","author":"JM Lee","year":"2017","unstructured":"Lee JM, Kim MK, Ko SH, Koh JM, Kim BY, Kim SW, et al. Clinical guidelines for the management of adrenal incidentaloma. Endocrinol Metab. 2017;32:200\u201318.","journal-title":"Endocrinol Metab"},{"issue":"11","key":"2781_CR11","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1007\/s00268-009-9999-0","volume":"33","author":"T Okamoto","year":"2009","unstructured":"Okamoto T, Iihara M, Obara T, Tsukada T. Parathyroid carcinoma: etiology, diagnosis, and treatment. World J Surg. 2009;33(11):2343\u201354. https:\/\/doi.org\/10.1007\/s00268-009-9999-0.","journal-title":"World J Surg"},{"issue":"7","key":"2781_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1507\/endocrj.EJ20-0025","volume":"67","author":"Y Ito","year":"2020","unstructured":"Ito Y, Onoda N, Okamoto T. The revised clinical practice guidelines on the management of thyroid tumors by the Japan associations of endocrine surgeons: core questions and recommendations for treatments of thyroid cancer. Endocr J. 2020;67(7):669\u2013717. https:\/\/doi.org\/10.1507\/endocrj.EJ20-0025. (Epub 2020 Apr 9).","journal-title":"Endocr J"},{"issue":"12","key":"2781_CR13","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/s40618-021-01615-3","volume":"44","author":"F Ceccato","year":"2021","unstructured":"Ceccato F, Barbot M, Scaroni C, Boscaro M. Frequently asked questions and answers (if any) in patients with adrenal incidentaloma. J Endocrinol Invest. 2021;44(12):2749\u201363. https:\/\/doi.org\/10.1007\/s40618-021-01615-3. (Epub 2021 Jun 23).","journal-title":"J Endocrinol Invest"},{"key":"2781_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2325\/jbcs.12.203","volume":"12","author":"T Okamoto","year":"2005","unstructured":"Okamoto T, Yamazaki K, Kanbe M, Kodama H, Omi Y, Kawamata A, et al. Probability of axillary lymph node metastasis when sentinel lymph node biopsy is negative in women with clinically node negative breast cancer: a Bayesian approach. Breast Cancer. 2005;12:203\u201310.","journal-title":"Breast Cancer"},{"key":"2781_CR15","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005574","volume":"6","author":"G Maiolino","year":"2017","unstructured":"Maiolino G, Rossitto G, Bisogni V, Cesari M, Seccia TM, Plebani M, PAPY Study Investigators, et al. Quantitative value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: the aldosterone-renin ratio for primary aldosteronism (AQUARR) study. J Am Heart Assoc. 2017;6: e005574.","journal-title":"J Am Heart Assoc"},{"key":"2781_CR16","doi-asserted-by":"publisher","first-page":"dgaa105","DOI":"10.1210\/clinem\/dgaa105","volume":"105","author":"BP Galm","year":"2020","unstructured":"Galm BP, Qiao N, Klibanski A, Biller BMK, Tritos NA. Accuracy of laboratory tests for the diagnosis of Cushing syndrome. J Clin Endocrinol Metab. 2020;105:dgaa105. https:\/\/doi.org\/10.1210\/clinem\/dgaa105.","journal-title":"J Clin Endocrinol Metab"},{"key":"2781_CR17","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1507\/endocrj.EJ13-0277","volume":"61","author":"Y Tanaka","year":"2014","unstructured":"Tanaka Y, Isobe K, Ma E, Imai T, Kikumori T, Matsuda T, et al. Plasma free metanephrines in the diagnosis of pheochromocytoma: diagnostic accuracy and strategies for Japanese patients. Endocr J. 2014;61:667\u201373.","journal-title":"Endocr J"},{"key":"2781_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1507\/endocrj.EJ15-0404","volume":"63","author":"Y Tabuchi","year":"2016","unstructured":"Tabuchi Y, Otsuki M, Kasayama S, Kosugi K, Hashimoto K, Yamamoto T, et al. Clinical and endocrinological characteristics of adrenal incidentaloma in Osaka region. Japan Endocr J. 2016;63:29\u201335.","journal-title":"Japan Endocr J"},{"issue":"2","key":"2781_CR19","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42(2):1235\u2013481.","journal-title":"Hypertens Res"},{"key":"2781_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","volume":"58","author":"T Nishikawa","year":"2009","unstructured":"Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, et al. Guidelines for the diagnosis and treatment of primary aldosteronism-the Japan endocrine society. Endocr J. 2009;58:711\u201321.","journal-title":"Endocr J"},{"key":"2781_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","volume":"69","author":"M Naruse","year":"2022","unstructured":"Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, et al. Japan endocrine society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J. 2022;69:327\u201359.","journal-title":"Endocr J"},{"issue":"1","key":"2781_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1507\/endocrj.EJ21-0278","volume":"69","author":"T Nishikawa","year":"2022","unstructured":"Nishikawa T, Satoh F, Takashi Y, Yanase T, Itoh H, Kurihara I, et al. Comparison and commutability study between standardized liquid chromatography-mass spectrometry\/mass spectrometry (LC-MS\/MS) and chemiluminescent enzyme immunoassay for aldosterone measurement in blood. Endocr J. 2022;69(1):45\u201354. https:\/\/doi.org\/10.1507\/endocrj.EJ21-0278. (Epub 2021 Jul 22).","journal-title":"Endocr J"},{"key":"2781_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1507\/endocrj.EJ17-0456","volume":"65","author":"T Yanase","year":"2018","unstructured":"Yanase T, Oki Y, Katabami T, Otsuki M, Kageyama K, Tanaka T, et al. New diagnostic criteria of adrenal subclinical Cushing\u2019s syndrome: opinion from the Japan endocrine society. Endocr J. 2018;65:383\u201393.","journal-title":"Endocr J"},{"key":"2781_CR24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1530\/EJE-07-0778","volume":"158","author":"AL Rosas","year":"2008","unstructured":"Rosas AL, Kasperlik-Zaluska AA, Papierska L, Bass BL, Pacak K, Eisenhofer G. Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature. Eur J Endocrinol. 2008;158:423\u20139.","journal-title":"Eur J Endocrinol"},{"key":"2781_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12020-009-9303-y","volume":"37","author":"DW Yi","year":"2010","unstructured":"Yi DW, Kim SY, Shin DH, Kang YH, Son SM. Pheochromocytoma crisis after a dexamethasone suppression test for adrenal incidentaloma. Endocrine. 2010;37:213\u20139.","journal-title":"Endocrine"},{"issue":"11","key":"2781_CR26","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","volume":"287","author":"JW Lenders","year":"2002","unstructured":"Lenders JW, Pacak K, Walther MM, Linehan WM, Manneli M, Friberg R, et al. Biochemical diagnosis of pheochromocytoma. Which test is best? JAMA. 2002;287(11):1427\u201334.","journal-title":"JAMA"},{"key":"2781_CR27","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s002689900453","volume":"22","author":"Y Ito","year":"1998","unstructured":"Ito Y, Obara T, Okamoto T, Kanbe M, Tanaka R, Iihara M, et al. Efficacy of single-voided urine metanephrine and normetanephrine assay for diagnosing pheochromocytoma. World J Surg. 1998;22:684\u20138.","journal-title":"World J Surg"},{"key":"2781_CR28","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1210\/jc.2017-01774","volume":"103","author":"H Umakoshi","year":"2018","unstructured":"Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Katabami T, et al. Significance of computed tomography and serum potassium in predicting subtype diagnosis of primary aldosteronism. J Clin Endocrinol Metab. 2018;103:900\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"2781_CR29","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1097\/HJH.0000000000001855","volume":"36","author":"H Kobayashi","year":"2018","unstructured":"Kobayashi H, Abe M, Soma M, Takeda Y, Kurihara I, Itoh H, et al. Development and validation of subtype prediction scores for the workup of primary aldosteronism. J Hypertension. 2018;36:2269\u201376.","journal-title":"J Hypertension"},{"key":"2781_CR30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/cen.13582","volume":"88","author":"H Umakoshi","year":"2018","unstructured":"Umakoshi H, Ogasawara T, Takeda Y, Kurihara I, Itoh H, Katabami T, et al. Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism. Clin Endoc. 2018;88:645\u201351.","journal-title":"Clin Endoc"},{"key":"2781_CR31","doi-asserted-by":"crossref","unstructured":"The Japan endocrine society: clinical practice guideline of pheochromocytoma paraganglioma 2018. (in Japanese) Folia Endocrinologica Japania 2018; 94;1\u201390","DOI":"10.1507\/endocrine.94.S.December_1"},{"issue":"2","key":"2781_CR32","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1530\/EJE-16-0461","volume":"175","author":"J Dinnes","year":"2016","unstructured":"Dinnes J, Bancos I, Ferrante di Ruffano L, Chortis V, Davenport C, Bayliss S, et al. Imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis. Eur J Endocrinol. 2016;175(2):R51\u201364.","journal-title":"Eur J Endocrinol"},{"key":"2781_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40200-016-0224-z","volume":"15","author":"FA Sabat","year":"2016","unstructured":"Sabat FA, Majdzadeh R, Mostafazadeh B, Heidari K, Soltani A. Likelihood ratio of computed tomography characteristics for diagnosis of malignancy in adrenal incidentaloma: systematic review and meta-analysis. Diabetes Metab Disord. 2016;15:12.","journal-title":"Diabetes Metab Disord"},{"key":"2781_CR34","doi-asserted-by":"publisher","first-page":"20170520","DOI":"10.1259\/bjr.20170520","volume":"91","author":"SJ Kim","year":"2018","unstructured":"Kim SJ, Lee SW, Pak K, Kim IJ, Kim K. Diagnostic accuracy of 18 F-FDG PET or PET\/CT for the characterization of adrenal masses: a systematic review and meta-analysis. Br J Radiol. 2018;91:20170520.","journal-title":"Br J Radiol"},{"key":"2781_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1677\/erc.1.01130","volume":"14","author":"R Libe","year":"2007","unstructured":"Libe R, Fratticci A, Bertherat J. Adrenocortical cancer: pathophysiology and clinical management. Endocr Relat Cancer. 2007;14:13\u201328.","journal-title":"Endocr Relat Cancer"},{"issue":"12","key":"2781_CR36","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1210\/jc.2013-3020","volume":"98","author":"M Fassnacht","year":"2013","unstructured":"Fassnacht M, Kroiss M, Allolo B. Update in adrenocortical carcinoma. J Clin Endocrinol Metab. 2013;98(12):4551\u201364.","journal-title":"J Clin Endocrinol Metab"},{"key":"2781_CR37","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","volume":"26","author":"LD Thompson","year":"2002","unstructured":"Thompson LD. Pheochromocytoma of the adrenal gland scaled score (PASS) to separate benign from malignant neoplasmas: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol. 2002;26:551\u201366.","journal-title":"Am J Surg Pathol"},{"key":"2781_CR38","first-page":"405","volume":"21","author":"N Kimura","year":"2014","unstructured":"Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, et al. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma Endocr-Relat. Cancer. 2014;21:405\u201314.","journal-title":"Cancer"},{"issue":"11","key":"2781_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187398","volume":"12","author":"JM Koh","year":"2017","unstructured":"Koh JM, Ahn SH, Kim H, Kim BJ, Sung TY, Kim YH, et al. Validation of pathological grading systems for predicting metastatic potential pheochromocytoma and paraganglioma. PLoS ONE. 2017;12(11): e0187398.","journal-title":"PLoS ONE"},{"key":"2781_CR40","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00428-019-02553-5","volume":"474","author":"C Pierre","year":"2019","unstructured":"Pierre C, Agopiantz M, Brunaud L, Battaglia-Hsu SF, Max A, Pouget C, et al. COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in pheochromocytomas\/paragangliomas. Virchows Arch. 2019;474:721\u201334.","journal-title":"Virchows Arch"},{"key":"2781_CR41","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.surg.2018.05.001","volume":"164","author":"YY Cho","year":"2018","unstructured":"Cho YY, Kwak MK, Lee SE, Ahn SH, Kim H, Suh S, et al. A clinical prediction model to estimate the metastatic potential of pheochromocytoma\/paraganglioma: ASES score. Surgery. 2018;164:511\u20137.","journal-title":"Surgery"},{"issue":"4","key":"2781_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1530\/EJE-19-0506","volume":"183","author":"F Majidi","year":"2020","unstructured":"Majidi F, Martino S, Kondakci M, Antke C, Haase M, Chortis V, et al. Clinical spectrum of primary adrenal lymphoma: results of multicenter cohort study. Eur J Endocrinol. 2020;183(4):453\u201362.","journal-title":"Eur J Endocrinol"},{"key":"2781_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.7326\/0003-4819-150-1-200901060-00006","volume":"150","author":"SK Baid","year":"2009","unstructured":"Baid SK, Lai EW, Wesley RA, Ling A, Timmers HJ, Adams KT, et al. Brief communication: radiographic contrast infusion and catecholamine release in patients with pheochromocytoma. Ann Intern Med. 2009;150:27\u201332.","journal-title":"Ann Intern Med"},{"key":"2781_CR44","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5:689\u201399.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2781_CR45","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/bjs.9742","volume":"102","author":"I Iacobone","year":"2015","unstructured":"Iacobone I, Citton M, Scarpa M, Viel G, Boscaro M, Nitti D. Systematic review of surgical treatment of subclinical Cushing\u2019s syndrome. Br J Surg. 2015;102:318\u201330.","journal-title":"Br J Surg"},{"key":"2781_CR46","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s12020-021-02843-6","volume":"74","author":"M Araujo-Castro","year":"2021","unstructured":"Araujo-Castro M, Garc\u00eda Centero R, L\u00f3pez-Garc\u00eda MC, \u00c1lvarez Escol\u00e1 C, Calatayud Guti\u00e9rrez M, Blanco Carrera C, et al. Surgical outcomes in the pheochromocytoma surgery. Results from the PHEO-RISK STUDY. Endocrine. 2021;74:676\u201384.","journal-title":"Endocrine"},{"key":"2781_CR47","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/ases.13012","volume":"15","author":"H Shiroshita","year":"2022","unstructured":"Shiroshita H, Inomata M, Akira S, Kanayama H, Yamaguchi S, Eguchi S, et al. Current status of endoscopic surgery in Japan: the 15th national survey of endoscopic surgery by the Japan society for endoscopic surgery. Asian J Endosc Surg. 2022;15:415\u201326.","journal-title":"Asian J Endosc Surg"},{"key":"2781_CR48","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/jch.12916","volume":"18","author":"JL Benham","year":"2016","unstructured":"Benham JL, Eldoma M, Khokhar B, Roberts DJ, Rabi DM, Kline GA. Proportion of patients with hypertension resolution following adrenalectomy for primary aldosteronism: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2016;18:1205\u201312.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2781_CR49","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/cen.14203","volume":"93","author":"R Nakamaru","year":"2020","unstructured":"Nakamaru R, Yamamoto K, Rakugi H, Akasaka H, Kurihara I, Ichijo T, JPAS\/JRAS Study Group, et al. Obesity predicts persistence of resistant hypertension after surgery in patients with primary aldosteronism. Clin Endocrinol (Oxf). 2020;93:229\u201337.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2781_CR50","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/SLA.0b013e318165c075","volume":"247","author":"R Zarnegar","year":"2008","unstructured":"Zarnegar R, et al. The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg. 2008;247:511\u20138.","journal-title":"Ann Surg"},{"key":"2781_CR51","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.amsu.2021.102333","volume":"65","author":"DPD Suurd","year":"2021","unstructured":"Suurd DPD, Visscher WP, Vorselaars WMCM, van Beek DJ, Spiering W, Borel Rinkes IHM, International CONNsortium Study Group, et al. A simplified primary aldosteronism surgical outcome score is a useful prediction model when target organ damage is unknown - retrospective cohort study. Ann Med Surg (Lond). 2021;65:1023. https:\/\/doi.org\/10.1016\/j.amsu.2021.102333. (eCollection 2021 May).","journal-title":"Ann Med Surg (Lond)"},{"key":"2781_CR52","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41440-019-0244-4","volume":"42","author":"M Satoh","year":"2019","unstructured":"Satoh M, Maruhashi T, Yoshida Y, Shibata H. Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism. Hypertens Res. 2019;42:817\u201324.","journal-title":"Hypertens Res"},{"key":"2781_CR53","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1097\/HJH.0000000000002070","volume":"37","author":"T Katabami","year":"2019","unstructured":"Katabami T, Fukuda H, Tsukiyama H, Tanaka Y, Takeda Y, Kurihara I, et al. Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism. J Hypertens. 2019;37:1513\u201320.","journal-title":"J Hypertens"},{"key":"2781_CR54","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1055\/s-0043-121706","volume":"49","author":"MS Velema","year":"2017","unstructured":"Velema MS, de Nooijer AH, Burgers VWG, Hermus ARMM, Timmers HJLM, Lenders JWM, et al. Health-related quality of life and mental health in primary aldosteronism: a systematic review. Horm Metab Res. 2017;49:943\u201350.","journal-title":"Horm Metab Res"},{"key":"2781_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13419","volume":"51","author":"F Buffolo","year":"2021","unstructured":"Buffolo F, Cavagli\u00e0 G, Burrello J, Amongero M, Tetti M, Pecori A, et al. Quality of life in primary aldosteronism: a prospective observational study. Eur J Clin Invest. 2021;51: e13419. https:\/\/doi.org\/10.1111\/eci.13419. (Epub 2020 Oct 14).","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"2781_CR56","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1530\/EC-21-0125","volume":"10","author":"YK Tan","year":"2021","unstructured":"Tan YK, Kwan YH, Teo DCL, Velema M, Deinum J, Tan PT, et al. Improvement in quality of life and psychological symptoms after treatment for primary aldosteronism: Asian Cohort study. Endocr Connect. 2021;10(8):834\u201344. https:\/\/doi.org\/10.1530\/EC-21-0125.","journal-title":"Endocr Connect"},{"key":"2781_CR57","doi-asserted-by":"publisher","first-page":"R283","DOI":"10.1530\/EJE-16-0465","volume":"175","author":"I Bancos","year":"2016","unstructured":"Bancos I, Alahdab F, Crowley RK, Chortis V, Delivanis DA, Erickson D, et al. THERAPY OF ENDOCRINE DISEASE: Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing\u2019s syndrome: a systematic review and meta-analysis. Eur J Endocrinol. 2016;175:R283\u201395.","journal-title":"Eur J Endocrinol"},{"key":"2781_CR58","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1055\/s-0032-1306294","volume":"44","author":"T Zelinka","year":"2012","unstructured":"Zelinka T, Petr\u00e1k O, Turkov\u00e1 H, et al. High incidence of cardiovascular complications in pheochromocytoma. Horm Metab Res. 2012;44:379\u201384.","journal-title":"Horm Metab Res"},{"key":"2781_CR59","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.1002\/bjs.11378","volume":"107","author":"H Groeben","year":"2020","unstructured":"Groeben H, Walz MK, Nottebaum BJ, Alesina PF, Greenwald A, Schumann R, et al. International multicentre review of perioperative management and outcome for catecholamine-producing tumours. Br J Surg. 2020;107:e170\u20138.","journal-title":"Br J Surg"},{"key":"2781_CR60","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.ejso.2020.02.009","volume":"46","author":"J Li","year":"2020","unstructured":"Li J, Wang Y, Chang X, Han Z. Laparoscopic adrenalectomy (LA) vs open adrenalectomy (OA) for pheochromocytoma (PHEO): a systematic review and meta-analysis. Eur J Surg Oncol. 2020;46:991\u20138.","journal-title":"Eur J Surg Oncol"},{"key":"2781_CR61","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12893-020-00824-6","volume":"20","author":"SQ Fu","year":"2020","unstructured":"Fu SQ, Wang SY, Chen Q, Liu YT, Li ZL, Sun T. Laparoscopic versus open surgery for pheochromocytoma: a meta-analysis. BMC Surg. 2020;20:167. https:\/\/doi.org\/10.1186\/s12893-020-00824-6.","journal-title":"BMC Surg"},{"issue":"2","key":"2781_CR62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.7326\/M18-3630","volume":"171","author":"YS Elhassan","year":"2019","unstructured":"Elhassan YS, Alahdab F, Prete A, Delivanis DA, Khanna A, Prokop L, et al. Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis. Ann Intern Med. 2019;171(2):107\u201316. https:\/\/doi.org\/10.7326\/M18-3630.","journal-title":"Ann Intern Med"},{"issue":"1","key":"2781_CR63","doi-asserted-by":"publisher","first-page":"77","DOI":"10.23736\/S0391-1977.16.02394-4","volume":"42","author":"HH Loh","year":"2017","unstructured":"Loh HH, Yee A, Loh HS, Sukor N, Kamaruddin NA. The natural progression and outcomes of adrenal incidentaloma: a systematic review and meta-analysis. Minerva Endocrinol. 2017;42(1):77\u201387. https:\/\/doi.org\/10.23736\/S0391-1977.16.02394-4.","journal-title":"Minerva Endocrinol"},{"issue":"3","key":"2781_CR64","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1530\/eje.1.02110","volume":"154","author":"B B\u00fclow","year":"2006","unstructured":"B\u00fclow B, Jansson S, Juhlin C, Steen L, Thor\u00e9n M, Wahrenberg H, et al. Adrenal incidentaloma - follow-up results from a Swedish prospective study. Eur J Endocrinol. 2006;154(3):419\u201323. https:\/\/doi.org\/10.1530\/eje.1.02110.","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2781_CR65","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/bjs.7566","volume":"98","author":"A Muth","year":"2011","unstructured":"Muth A, Hammarstedt L, Hellstr\u00f6m M, Sigurj\u00f3nsd\u00f3ttir H\u00c1, Almqvist E, Wangberg B, Adrenal Study Group of Western Sweden. Cohort study of patients with adrenal lesions discovered incidentally. Br J Surg. 2011;98(10):1383\u201391. https:\/\/doi.org\/10.1002\/bjs.7566.","journal-title":"Br J Surg"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-023-02781-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-023-02781-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-023-02781-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T08:07:27Z","timestamp":1732176447000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-023-02781-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":65,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["2781"],"URL":"https:\/\/doi.org\/10.1007\/s00595-023-02781-y","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,13]]},"assertion":[{"value":"24 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest in association with the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"As the present study used information from published articles only and did not obtain data at the individual patient level, ethical approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}